New Three-Drug attack on Tough-to-Treat bladder cancer
NCT ID NCT02420847
Summary
This study is testing a new combination of three drugs for advanced bladder cancer that has spread or cannot be surgically removed. The first part aims to find the safest and most effective doses. The second part will see how well the chosen dose combination works to shrink tumors and help patients live longer. The trial is for patients whose cancer has worsened after at least one prior treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.